Biotricity Q4 2024 Adj EPS $(0.47) Misses $(0.36) Estimate, Sales $3.200M Inline
Portfolio Pulse from Benzinga Newsdesk
Biotricity (NASDAQ:BTCY) reported a Q4 2024 adjusted EPS of $(0.47), missing the analyst estimate of $(0.36) by 30.56%. The company reported quarterly sales of $3.200 million, in line with estimates and a 16.79% increase from the same period last year.
June 27, 2024 | 12:26 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biotricity's Q4 2024 adjusted EPS of $(0.47) missed analyst estimates by 30.56%, while sales of $3.200 million met expectations and increased 16.79% YoY.
The significant miss on EPS estimates is likely to negatively impact investor sentiment and short-term stock price, despite the positive sales growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100